CRON vs. ACB, CGC, OGI, SNDL, TLRY, MOR, KYMR, ALVO, IMVT, and CRNX
Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), MorphoSys (MOR), Kymera Therapeutics (KYMR), Alvotech (ALVO), Immunovant (IMVT), and Crinetics Pharmaceuticals (CRNX). These companies are all part of the "medical" sector.
Cronos Group vs. Its Competitors
Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.
In the previous week, Cronos Group and Cronos Group both had 2 articles in the media. Cronos Group's average media sentiment score of 0.57 beat Aurora Cannabis' score of 0.00 indicating that Cronos Group is being referred to more favorably in the media.
Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.
8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 6.9% of Cronos Group shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Cronos Group has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500.
Cronos Group has a net margin of 39.69% compared to Aurora Cannabis' net margin of 1.32%. Aurora Cannabis' return on equity of 0.13% beat Cronos Group's return on equity.
Summary
Aurora Cannabis beats Cronos Group on 9 of the 15 factors compared between the two stocks.
Get Cronos Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Cronos Group Competitors List
Related Companies and Tools
This page (NASDAQ:CRON) was last updated on 7/9/2025 by MarketBeat.com Staff